Logo-apb

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308 
pISSN: 2228-5881 

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Powered by
Adv Pharm Bull. 2021;11(1): 96-103. doi: 10.34172/apb.2021.010
PMID: 33747856        PMCID: PMC7961234

Research Article

Lysine Decorated Solid Lipid Nanoparticles of Epirubicin for Cancer Targeting and Therapy

Parvaneh Bayat 1 ORCID, Parvaneh Pakravan 1 * ORCID, Mojtaba Salouti 2, Jafar Ezzati Nazhad Dolatabadi 3

Cited by CrossRef: 16

1- Chakraborty S, Dhibar M, Das A, Swain K, Pattnaik S. A Critical Appraisal of Lipid Nanoparticles Deployed in Cancer Pharmacotherapy. RADDF. 2023;17(2):132 [Crossref]
2- Prajapati A, Rangra S, Patil R, Desai N, Jyothi V, Salave S, Amate P, Benival D, Kommineni N. Receptor-Targeted Nanomedicine for Cancer Therapy. Receptors. 2024;3(3):323 [Crossref]
3- Ying N, Lin X, Xie M, Zeng D. Effect of surface ligand modification on the properties of anti-tumor nanocarrier. Colloids and Surfaces B: Biointerfaces. 2022;220:112944 [Crossref]
4- Moraes-Lacerda T, de Jesus M. Mechanisms of solid lipid nanoparticles-triggered signaling pathways in eukaryotic cells. Colloids and Surfaces B: Biointerfaces. 2022;220:112863 [Crossref]
5- Banthia P, Gambhir L, Sharma A, Daga D, Kapoor N, Chaudhary R, Sharma G. Nano to rescue: repository of nanocarriers for targeted drug delivery to curb breast cancer. 3 Biotech. 2022;12(3) [Crossref]
6- More S, Wadhokar A, Bedjawalge R. A Review on Solid Lipid Nanoparticles as Nano Drug Delivery Transporters. CNANO. 2024;20(5):644 [Crossref]
7- Luiz M, Dutra J, Di Filippo L, Junior A, Tofani L, Marchetti J, Chorilli M. Epirubicin: Biological Properties, Analytical Methods, and Drug Delivery Nanosystems. Critical Reviews in Analytical Chemistry. 2023;53(5):1080 [Crossref]
8- Saadat M, Jafari S, Mahmoudian M, Sarfraz M, Khaleseh F, Zakeri-Milani P, Shahbazi-Mojarrad J, Valizadeh H. Choline Based Surfactants Promote Cellular Uptake of Solid Lipid Nanoparticles into Lung and Breast Cancer Cells. CNANO. 2025;21(4):702 [Crossref]
9- Mottaqi M, Langarizadeh M, Molaali N, Rezaei M, Ameri A, Forootanfar H. The synthesis, application and therapeutic perspectives of medicinal plants-based solid lipid nanoparticles: a comprehensive review. ADV TRADIT MED (ADTM). 2025;25(1):69 [Crossref]
10- Behl A, Chhillar A. Nano-Based Drug Delivery of Anticancer Chemotherapeutic Drugs Targeting Breast Cancer. PRA. 2023;18(3):325 [Crossref]
11- Soltani A, Pakravan P. Preparation and Characterization of Magnetic Solid Lipid Nanoparticles as a Targeted Drug Delivery System for Doxorubicin. Adv Pharm Bull. 2023;13(2):301 [Crossref]
12- Li K, Pi C, Wen J, He Y, Yuan J, Shen H, Zhao W, Zeng M, Song X, Lee R, Wei Y, Zhao L. Formulation of the novel structure curcumin derivative–loaded solid lipid nanoparticles: synthesis, optimization, characterization and anti-tumor activity screening in vitro. Drug Delivery. 2022;29(1):2044 [Crossref]
13- Nguyen T, Pham K, Yook S. Engineered therapeutic proteins for sustained-release drug delivery systems. Acta Biomaterialia. 2023;171:131 [Crossref]
14- Rahman M, Afzal O, Ullah S, Alshahrani M, Alkhathami A, Altamimi A, Almujri S, Almalki W, Shorog E, Alossaimi M, Mandal A, abdulrahman A, Sahoo A. Nanomedicine-Based Drug-Targeting in Breast Cancer: Pharmacokinetics, Clinical Progress, and Challenges. ACS Omega. 2023;8(51):48625 [Crossref]
15- Kaur N, Popli P, Tiwary N, Swami R. Small molecules as cancer targeting ligands: Shifting the paradigm. Journal of Controlled Release. 2023;355:417 [Crossref]